Urinary concentration of phthalates and bisphenol A during minipuberty is associated with reproductive hormone
Matilde Lærkeholm Müller1, Alexander Siegfried Busch2, Marie Lindhardt Ljubicic1
1Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Insights
Exposure to endocrine disrupting chemicals like DnBP, DEHP, and BPA during infant minipuberty may alter male reproductive hormone levels. This critical developmental window is sensitive to chemical exposures, impacting hormonal balance in infant boys.
Area of Science:
- Endocrinology
- Environmental Health
- Pediatrics
Background:
- Minipuberty, a transient postnatal activation of the hypothalamic-pituitary-gonadal axis, is a crucial developmental stage highly susceptible to endocrine disruption.
- Investigating the impact of environmental chemical exposures on male reproductive hormones during this sensitive period is vital for understanding long-term health implications.
Purpose of the Study:
- To explore the associations between urinary concentrations of potential endocrine disrupting chemicals (EDCs) and serum reproductive hormone levels in infant boys during minipuberty.
- To identify specific EDCs that may affect male reproductive hormone concentrations during this critical developmental window.
Main Methods:
- Analysis of serum reproductive hormones and urinary EDC metabolites in 36 infant boys from the COPENHAGEN Minipuberty Study.
- Measurement of urinary concentrations of 39 non-persisting chemicals, including phthalates and phenolic compounds, using LC-MS/MS.
- Statistical analysis using linear regression to assess associations between urinary EDC metabolite concentrations (in tertiles) and hormone outcomes (age- and sex-specific SD-scores).
Main Results:
- Urinary di-n-butyl phthalate (DnBP) metabolite concentrations were associated with altered luteinizing hormone (LH), anti-Müllerian hormone (AMH), testosterone/LH ratio, and insulin-like peptide 3 (INSL3) levels.
- Urinary di-(2-ethylhexyl) phthalate (DEHP) metabolite concentrations were linked to higher LH and AMH levels.
- Higher urinary bisphenol A (BPA) concentrations were associated with significantly higher AMH and lower dehydroepiandrosterone sulfate (DHEAS) levels.
Conclusions:
- Exposure to EU-regulated chemicals such as DnBP, DEHP, and BPA during infant minipuberty may modify male reproductive hormone concentrations.
- Minipuberty represents a critical developmental window sensitive to endocrine disruption by environmental chemicals.
- These findings highlight the potential risks of EDC exposure on male reproductive development during early life.
Background:
The transient postnatal activation of the hypothalamic-pituitary-gonadal hormone axis is termed minipuberty and considered an important developmental period, which is highly sensitive to endocrine disruption. Here, we explore exposure-outcome associations during minipuberty between concentrations of potentially endocrine disrupting chemicals (EDCs) in urine of infant boys and their serum reproductive hormone concentrations.
Methods:
In total, 36 boys participating in the COPENHAGEN Minipuberty Study had data available for both urine biomarkers of target endocrine disrupting chemicals and reproductive hormones in serum from samples collected on the same day. Serum concentrations of reproductive hormones were measured by immunoassays or by LC-MS/MS. Urinary concentrations of metabolites of 39 non-persisting chemicals, including phthalates and phenolic compounds, were measured by LC-MS/MS. Nineteen chemicals had concentrations above the limit of detection in ≥50% of children and were included in data analysis. Associations of urinary phthalate metabolite and phenol concentrations (in tertiles) with hormone outcomes (age- and sex-specific SD-scores) were analysed by linear regression. Primarily, we focused on the EU regulated phthalates; butylbenzyl phthalate (BBzP), di-iso-butyl phthalate (DiBP), di-n-butyl phthalate (DnBP), and di-(2-ethylhexyl) phthalate (DEHP) as well as bisphenol A (BPA). Urinary metabolites of DiBP, DnBP and DEHP were summed and expressed as ∑DiBPm, ∑DnBPm and ∑DEHPm.
Results:
Compared to boys in the lowest ∑DnBPm tertile, urinary concentration of ∑DnBPm was associated with concurrent higher luteinizing hormone (LH) and anti-Müllerian hormone (AMH) SD-scores as well as lower testosterone/LH ratio in boys in the middle ∑DnBPm tertile (estimates (CI 95%) 0.79 (0.04; 1.54), 0.91 (0.13; 1.68), and -0.88 (-1.58;-0.19), respectively). Further, higher insulin-like peptide 3 (INSL3) SD-scores and lower DHEAS SD-score in boys in the highest ∑DnBPm tertile (0.91 (0.12; 1.70) and -0.85 (-1.51;-0.18), respectively) were observed. In addition, boys in the middle and highest ∑DEHPm tertile had higher LH (1.07 (0.35; 1.79) and 0.71 (-0.01; 1.43), respectively) and in the highest ∑DEHPm tertile also higher AMH (0.85 (0.10; 1.61)) concentration SD-scores, respectively. Boys in the highest BPA tertile had significantly higher AMH and lower DHEAS concentration compared to boys in the lowest BPA tertile (1.28 (0.54; 2.02) and -0.73 (-1.45; -0.01)), respectively.
Discussion:
Our findings indicate that exposure to chemicals with known or suspected endocrine disrupting potential, especially the EU-regulated DnBP, DEHP and BPA, may modify male reproductive hormone concentrations in infant boys suggesting that minipuberty is a critical window sensitive to endocrine disruption.
Related Concept Videos
Signs of Puberty
Psychosexual Stages of Personality: Phallic
Teratogenicity


